{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:08:38Z","timestamp":1794316118466,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013263","name":"Norwegian Health Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>Some studies point to sex differences in cardiovascular preventive practices. The aim of this study was to investigate differences in achievement of secondary preventive targets and long-term outcome in men and women after a coronary heart event.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study was a subanalysis from a randomized controlled trial of hospital-based versus primary care-based secondary preventive follow-up at Sorlandet Hospital, Norway, 2007\u20132022 and included both groups. The main outcome was achievement of treatment targets two years after the index event. Event-free survival was calculated based on the composite of mortality, coronary intervention, stroke, or myocardial infarction during follow-up. Participants were followed-up for up to 10\u00a0years after the index event through out-patient consultations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 337 women and 1203 men were eligible for the study. Due to loss of follow-up during the first two years after the index coronary event 106 (7%) participants were excluded from further analysis (53% withdrawal of consent, 12% death, and 35% other causes) leaving 307 (21%) women and 1127 (79%) men. After two years of follow-up we found no differences between women and men in achievement of blood pressure targets (61% vs. 59%; <jats:italic>p<\/jats:italic>\u2009=\u20090.57), LDL-cholesterol goals (64% vs. 69%; <jats:italic>p<\/jats:italic>\u2009=\u20090.15), HbA1c-goal in patients with diabetes (49% vs. 45%; <jats:italic>p<\/jats:italic>\u2009=\u20090.57), non-smoking (79% vs. 81%; <jats:italic>p<\/jats:italic>\u2009=\u20090.34), healthy diets (14% vs. 13%, <jats:italic>p<\/jats:italic>\u2009=\u20090.89), physical activity (55% vs. 58%; <jats:italic>p<\/jats:italic>\u2009=\u20090.38), use of acetylsalicylic acid (93% vs. 94%; <jats:italic>p<\/jats:italic>\u2009=\u20090.39), and use of lipid lowering therapy (92% vs. 94%; <jats:italic>p<\/jats:italic>\u2009=\u20090.15). After a median follow-up time of 5.0 [SD 3.2] years there were no differences between women and men regarding composite endpoint (89 [30.0%] vs. 345 [30.6]; <jats:italic>p<\/jats:italic>\u2009=\u20090.58), and composite endpoint-free survival did not differ between women and men (hospital-based follow-up HR for women versus men, 0.87, 95% CI 0.62\u20131.23; <jats:italic>p<\/jats:italic>\u2009=\u20090.44 and primary care service HR for women versus men 0.95, 95% CI 0.69\u20131.31; <jats:italic>p<\/jats:italic>\u2009=\u20090.78).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study show no sex differences in achievement of secondary preventive targets or composite endpoint after coronary heart events. However, many women and men did not achieve treatment goals, and further improvement in secondary prevention is needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study is registered in ClinicalTrials.gov (NCT00679237).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03483-6","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:50:21Z","timestamp":1694703021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex differences in secondary preventive follow-up after coronary heart events"],"prefix":"10.1186","volume":"23","author":[{"given":"Anete","family":"Kaldal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Tonstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarle","family":"Jortveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"3483_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","volume":"43","author":"A Timmis","year":"2022","unstructured":"Timmis A, Vardas P, Townsend N, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716\u201399. https:\/\/doi.org\/10.1093\/eurheartj\/ehab892.","journal-title":"Eur Heart J"},{"key":"3483_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12872-019-1062-y","volume":"19","author":"J Jortveit","year":"2019","unstructured":"Jortveit J, Halvorsen S, Kaldal A, et al. Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease. BMC Cardiovasc Disord. 2019;19:71. https:\/\/doi.org\/10.1186\/s12872-019-1062-y.","journal-title":"BMC Cardiovasc Disord"},{"key":"3483_CR3","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"SC Smith","year":"2011","unstructured":"Smith SC, Benjamin EJ, Bonow RO, et al. AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. J Am Coll Cardiol. 2011;58:2432. https:\/\/doi.org\/10.1016\/j.jacc.2011.10.824.","journal-title":"J Am Coll Cardiol"},{"key":"3483_CR4","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227\u2013337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484.","journal-title":"Eur Heart J"},{"key":"3483_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/s0140-6736(09)60330-5","volume":"373","author":"K Kotseva","year":"2009","unstructured":"Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929\u201340. https:\/\/doi.org\/10.1016\/s0140-6736(09)60330-5.","journal-title":"Lancet"},{"key":"3483_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/2047487315569401","volume":"23","author":"K Kotseva","year":"2016","unstructured":"Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23:636\u201348. https:\/\/doi.org\/10.1177\/2047487315569401.","journal-title":"Eur J Prev Cardiol"},{"key":"3483_CR7","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1177\/2047487314547652","volume":"22","author":"R Ferrari","year":"2014","unstructured":"Ferrari R, Ford I, Greenlaw N, et al. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry. Eur J Prev Cardiol. 2014;22:1056\u201365. https:\/\/doi.org\/10.1177\/2047487314547652.","journal-title":"Eur J Prev Cardiol"},{"key":"3483_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/hrt.2010.213710","volume":"97","author":"PP Cacoub","year":"2011","unstructured":"Cacoub PP, Zeymer U, Limbourg T, et al. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart. 2011;97:660. https:\/\/doi.org\/10.1136\/hrt.2010.213710.","journal-title":"Heart"},{"key":"3483_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/IJWH.S107371","volume":"10","author":"J Chandrasekhar","year":"2018","unstructured":"Chandrasekhar J, Gill A, Mehran R. Acute myocardial infarction in young women: current perspectives. Int J Womens Health. 2018;10:267\u201384. https:\/\/doi.org\/10.2147\/IJWH.S107371.","journal-title":"Int J Womens Health"},{"key":"3483_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1161\/CIRCULATIONAHA.116.024993","volume":"135","author":"RP Dreyer","year":"2017","unstructured":"Dreyer RP, Dharmarajan K, Kennedy KF, et al. Sex differences in 1-year all-cause rehospitalization in patients after acute myocardial infarction: a prospective observational study. Circulation. 2017;135:521\u201331. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024993.","journal-title":"Circulation"},{"key":"3483_CR11","doi-asserted-by":"publisher","unstructured":"Liu J, Elbadawi A, Elgendy IY, et al. Age-stratified sex disparities in care and outcomes in patients with ST-elevation myocardial infarction. Am J Med. 2020;133:1293\u2013301. e1291. https:\/\/doi.org\/10.1016\/j.amjmed.2020.03.059","DOI":"10.1016\/j.amjmed.2020.03.059"},{"key":"3483_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.amjcard.2016.09.052","volume":"119","author":"V Kunadian","year":"2017","unstructured":"Kunadian V, Qiu W, Lagerqvist B, et al. Gender differences in outcomes and predictors of all-cause mortality after percutaneous coronary intervention (Data from United Kingdom and Sweden). Am J Cardiol. 2017;119:210\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2016.09.052.","journal-title":"Am J Cardiol"},{"key":"3483_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000351","author":"LS Mehta","year":"2016","unstructured":"Mehta LS, Beckie TM, DeVon HA, et al. Acute myocardial infarction in women: a scientific statement From the American Heart Association. Circulation. 2016. https:\/\/doi.org\/10.1161\/CIR.0000000000000351.","journal-title":"Circulation"},{"key":"3483_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.ijcard.2012.10.028","volume":"168","author":"SS Lawesson","year":"2013","unstructured":"Lawesson SS, Alfredsson J, Fredrikson M, et al. A gender perspective on short- and long term mortality in ST-elevation myocardial infarction\u2013a report from the SWEDEHEART register. Int J Cardiol. 2013;168:1041\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2012.10.028.","journal-title":"Int J Cardiol"},{"key":"3483_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/CIRCULATIONAHA.114.009480","volume":"130","author":"EM Bucholz","year":"2014","unstructured":"Bucholz EM, Butala NM, Rathore SS, et al. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130:757\u201367. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.009480.","journal-title":"Circulation"},{"key":"3483_CR16","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1111\/dme.12084","volume":"30","author":"G Egiziano","year":"2013","unstructured":"Egiziano G, Akhtari S, Pilote L, et al. Sex differences in young patients with acute myocardial infarction. Diabet Med. 2013;30:e108-114. https:\/\/doi.org\/10.1111\/dme.12084.","journal-title":"Diabet Med"},{"key":"3483_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.hlc.2013.03.078","volume":"22","author":"RP Dreyer","year":"2013","unstructured":"Dreyer RP, Beltrame JF, Tavella R, et al. Evaluation of gender differences in door-to-balloon time in ST-elevation myocardial infarction. Heart Lung Circ. 2013;22:861\u20139. https:\/\/doi.org\/10.1016\/j.hlc.2013.03.078.","journal-title":"Heart Lung Circ"},{"key":"3483_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.106.664979","volume":"115","author":"C Milcent","year":"2007","unstructured":"Milcent C, Dormont B, Durand-Zaleski I, et al. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation. 2007;115:833\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.664979.","journal-title":"Circulation"},{"key":"3483_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2005.05.091","volume":"46","author":"SS Anand","year":"2005","unstructured":"Anand SS, Xie CC, Mehta S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005;46:1845\u201351. https:\/\/doi.org\/10.1016\/j.jacc.2005.05.091.","journal-title":"J Am Coll Cardiol"},{"key":"3483_CR20","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.amjcard.2015.03.006","volume":"115","author":"N Johnston","year":"2015","unstructured":"Johnston N, Jonelid B, Christersson C, et al. Effect of gender on patients with ST-elevation and non-st-elevation myocardial infarction without obstructive coronary artery disease. Am J Cardiol. 2015;115:1661\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2015.03.006.","journal-title":"Am J Cardiol"},{"key":"3483_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.2012.199","volume":"307","author":"JG Canto","year":"2012","unstructured":"Canto JG, Rogers WJ, Goldberg RJ, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307:813\u201322. https:\/\/doi.org\/10.1001\/jama.2012.199.","journal-title":"JAMA"},{"key":"3483_CR22","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/eurheartj\/ehp493","volume":"31","author":"A Hvelplund","year":"2010","unstructured":"Hvelplund A, Galatius S, Madsen M, et al. Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. Eur Heart J. 2010;31:684\u201390. https:\/\/doi.org\/10.1093\/eurheartj\/ehp493.","journal-title":"Eur Heart J"},{"key":"3483_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijcard.2015.08.065","volume":"201","author":"MP Donataccio","year":"2015","unstructured":"Donataccio MP, Puymirat E, Parapid B, et al. In-hospital outcomes and long-term mortality according to sex and management strategy in acute myocardial infarction. Insights from the French ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) 2005 Registry. Int J Cardiol. 2015;201:265\u201370. https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.065.","journal-title":"Int J Cardiol"},{"key":"3483_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.4045\/tidsskr.16.0224","volume":"136","author":"J Jortveit","year":"2016","unstructured":"Jortveit J, Govatsmark RE, Langorgen J, et al. Gender differences in the assessment and treatment of myocardial infarction. Tidsskr Nor Laegeforen. 2016;136:1215\u201322. https:\/\/doi.org\/10.4045\/tidsskr.16.0224.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"3483_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.hlc.2020.06.026","volume":"30","author":"K Hyun","year":"2021","unstructured":"Hyun K, Negrone A, Redfern J, et al. Gender difference in secondary prevention of cardiovascular disease and outcomes following the survival of acute coronary syndrome. Heart Lung Circ. 2021;30:121\u20137. https:\/\/doi.org\/10.1016\/j.hlc.2020.06.026.","journal-title":"Heart Lung Circ"},{"key":"3483_CR26","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1136\/heartjnl-2019-315134","volume":"105","author":"CMY Lee","year":"2019","unstructured":"Lee CMY, Mnatzaganian G, Woodward M, et al. Sex disparities in the management of coronary heart disease in general practices in Australia. Heart. 2019;105:1898\u2013904. https:\/\/doi.org\/10.1136\/heartjnl-2019-315134.","journal-title":"Heart"},{"key":"3483_CR27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s12872-021-02426-3","volume":"21","author":"A Kaldal","year":"2021","unstructured":"Kaldal A, Tonstad S, Jortveit J. Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial. BMC Cardiovasc Disord. 2021;21:600. https:\/\/doi.org\/10.1186\/s12872-021-02426-3.","journal-title":"BMC Cardiovasc Disord"},{"key":"3483_CR28","first-page":"60","volume":"12","author":"A Svilaas","year":"2002","unstructured":"Svilaas A, Str\u00f6m EC, Svilaas T, et al. Reproducibility and validity of a short food questionnaire for the assessment of dietary habits. Nutr Metab Cardiovasc Dis. 2002;12:60\u201370.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3483_CR29","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","volume":"28","author":"I Graham","year":"2007","unstructured":"Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: fourth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehm316.","journal-title":"Eur Heart J"},{"key":"3483_CR30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"J Perk","year":"2012","unstructured":"Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635\u2013701. https:\/\/doi.org\/10.1093\/eurheartj\/ehs092.","journal-title":"Eur Heart J"},{"key":"3483_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet J-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267\u2013315. https:\/\/doi.org\/10.1093\/eurheartj\/ehv320.","journal-title":"Eur Heart J"},{"key":"3483_CR32","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315\u201381. https:\/\/doi.org\/10.1093\/eurheartj\/ehw106.","journal-title":"Eur Heart J"},{"key":"3483_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39:119\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.","journal-title":"Eur Heart J"},{"key":"3483_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019;41:111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"key":"3483_CR35","doi-asserted-by":"publisher","unstructured":"Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575.","DOI":"10.1093\/eurheartj\/ehaa575"},{"key":"3483_CR36","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.mayocp.2018.04.019","volume":"93","author":"NR Smilowitz","year":"2018","unstructured":"Smilowitz NR, Gupta N, Guo Y, et al. Acute Myocardial Infarction During Pregnancy and the Puerperium in the United States. Mayo Clin Proc. 2018;93:1404\u201314. https:\/\/doi.org\/10.1016\/j.mayocp.2018.04.019.","journal-title":"Mayo Clin Proc"},{"key":"3483_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrcardio.2016.89","volume":"13","author":"NJ Pagidipati","year":"2016","unstructured":"Pagidipati NJ, Peterson ED. Acute coronary syndromes in women and men. Nat Rev Cardiol. 2016;13:471\u201380. https:\/\/doi.org\/10.1038\/nrcardio.2016.89.","journal-title":"Nat Rev Cardiol"},{"key":"3483_CR38","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIR.0000000000000351","volume":"133","author":"LS Mehta","year":"2016","unstructured":"Mehta LS, Beckie TM, DeVon HA, et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133:916\u201347. https:\/\/doi.org\/10.1161\/CIR.0000000000000351.","journal-title":"Circulation"},{"key":"3483_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1403494818803256","volume":"48","author":"RES Govatsmark","year":"2020","unstructured":"Govatsmark RES, Janszky I, Slordahl SA, et al. Completeness and correctness of acute myocardial infarction diagnoses in a medical quality register and an administrative health register. Scand J Public Health. 2020;48:5\u201313. https:\/\/doi.org\/10.1177\/1403494818803256.","journal-title":"Scand J Public Health"},{"key":"3483_CR40","doi-asserted-by":"publisher","first-page":"e84285","DOI":"10.1371\/journal.pone.0084285","volume":"9","author":"GY Stein","year":"2014","unstructured":"Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction\u2013patient characteristics, management and outcomes. PLoS One. 2014;9:e84285. https:\/\/doi.org\/10.1371\/journal.pone.0084285.","journal-title":"PLoS One"},{"key":"3483_CR41","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jacc.2020.12.031","volume":"77","author":"ES Lau","year":"2021","unstructured":"Lau ES, Hayes SN, Volgman AS, et al. Does patient-physician gender concordance influence patient perceptions or outcomes? J Am Coll Cardiol. 2021;77:1135\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2020.12.031.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03483-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03483-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03483-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T12:12:38Z","timestamp":1700395958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03483-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3483"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03483-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Regional Committee for Medical and Health Research Ethics (REK, 2.2007.248). All study participants have signed a written consent form. The data collection, storage and processing were approved by Norwegian Social Science Data Services (NSD, 2007\/17221). The study is registered in ClinicalTrials.gov (16.05.2008, NCT00679237). The study was carried out in accordance with Helsinki declaration, and written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AK declares no conflicts of interest.ST has received speaking fees from Pfizer.JJ has received speaking fees from Amgen, AstraZeneca, BMS, Boehringer Ingelheim, Novartis, Pfizer, and Sanofi.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"459"}}